Leads continuous improvement practices globally for BioServices and Specialty Logistics, drives KPI accountability and a culture of continuous improvement, and supports realization of Senior Leadership strategic objectives.* Overachieved AOP by 18% despite productivity savings target increasing 66% in 3 years.* Led, supported, or ensured successful completion of dozens of projects or initiatives with measurable reductions in waste, increases in revenue, or improvements in quality and safety.* Developed a strategy and diplomatically cultivated a culture of continuous improvement: - Increased unique Gemba participation by 58%, - Redesigned Tier Management structure aligning KPIs with improved communication and problem solving, - Implemented a competitive program and reward system to encourage increased JDI participation, and - Designed and distributed quarterly PPI newsletters of achievements, initiatives, and best practices.* Provided coaching, mentoring, training, and support for all functional teams. - Supervised performance and developed two PPI Specialists and a Data Analyst in EMEA and the US, - Produced monthly Core PPI Training, Lunch N’ Learns, and best practice communications, - Directed the development and expansion of our PPI Ambassador program to 24 participants, - Oversaw the execution and sustainability of projects facilitated by certified Process Managers, and - Maintained monthly touch points with all Site Leads and Functional Leads as Leader Standard Work.* Trusted resource selected to facilitate complicated and sensitive projects or division-wide initiatives

Responsible for maintaining operations of the CDC Biorepository including staffing, sample management, cryogenic services, customer requests, and developing process improvements.* Grew contract by 25% more billable headcount in a 12-month period.* Established a culture of accountability and quality resulting in 0 deficiencies following a 2021 CAP inspection.* Developed, communicated, and monitored KPIs that aligned with strategic objectives.* Recruited, trained, supervised, and mentored Team Leaders and laboratory, cryogenic, and transportation staff.* Prepared and presented operating reports on biorepository activities to meet company and customer requirements.* Assisted in managing operating budgets to ensure fiscal accountability* Implemented Thermo Fisher’s TPS-based PPI business system to improve site operations: - Used Lean Management tools to increase productivity 84%, while improving quality and safety, - Designed and project managed site-wide LN2 unit excessing, replacement, and reorganization, - Led a Kaizen to redesign the file naming and management processes, - Piloted and standardized a process for sample auditing and consolidation, and - Implemented 5S and Standard Work to streamline sample retrievals from chest freezers.

Directed reference lab operations under CLIA regulations and a QMS system that includes clinical diagnostic testing, outbreak response, public health lab technical assistance, budget management, and overseeing research projects.* Managed lab workflow: sample accessioning, culturing, qPCR typing, phenotypic characterization, whole genome sequencing, source attribution, and data management. Prepared and submitted final reports.* Implemented and oversaw quality assurance of work, proficiency testing, and assay training; authored or revised SOPs, Job Aids, and other technical documents.* Mentored and supported direct reports by identifying training opportunities, providing positive feedback, leading performance evaluations, and engaging in corrective counseling.* Advised on and coordinated research project goals to align with short- and long-term public health initiatives.* Collaborated with and provides expert scientific advice or policy recommendations to all organizational levels of CDC, state and local health agencies, and external national and international partner organizations.

Negotiated confidential disclosure, material transfer, and collaborative research agreements with national and international private and non-profit partners. Critically assessed research projects for novel intellectual property and the public health impacts in patenting technologies.* Responsible manager for several team members and new hires, providing mentorship and oversight of their work products to ensure consistent application of office policies and accelerate new hire contributions. * Trained scientists and leadership in CDC policies and procedures, promoted tech transfer best practices, and built new partnerships.* Project managed several quality enhancement and efficiency improvements: an agency-wide documentation system for verifying human subject protections, revised file naming and document management processes, database record management and quality controls, and new request tracking systems.

Developed a cell-based assay for quantitative assessment of functional antibodies against pertussis for determination of vaccination efficacy. Maintained proficiency for a CLIA-approved anthrax diagnostic ELISA test.Principal Investigator: Conrad Quinn* Applied expert scientific knowledge to identify and eliminate variables contributing to high intra-assay error and recommend quality controls for improved assay performance.* Co-authored the Development Report and SOPs detailing the use of the assay and RTCA Xcelligence system.* Authored and reviewed SOPs for various laboratory policies and procedures to ensure quality management of data and lab safety.* Provided guidance and ensured adherence to laboratory regulations, revised protocols for proper maintenance of laboratory equipment.

Project Scope: Investigation of the regulation of a Neisseria meningitidis surface protein required for attachment to and invasion of human epithelial cells. This protein is present in 100% of hypervirulent meningococcal strains and is a current vaccine target candidate.Principal Investigator: Dr. William ShaferDesigned and conducted research studies that determined host factors affecting regulation of a surface protein required for infection by bacterial meningitis.* Determined genetic differences between the regulators of a multi-antimicrobial drug export pump in Neisseria meningitidis and Neisseria gonorrhoeae.* Advanced the understanding of antimicrobial resistance in bacterial pathogens and promoted selective antibiotic use.* Presented scientific data at the Multi-Drug Efflux Pump Gordon Research Conference in Switzerland while identifying potential collaborative opportunities.* Mentored and trained graduate students on proper laboratory technique and safety, provided expert advice in enhancing an experimental design, expanding theories, and offering new or alternative interpretations of data.

• Evaluate commercial viability of disclosed inventions (diagnostics, therapeutics, research tools, and medical devices)• Assess patentability following prior art searches• Conduct market research analyses and develop marketing strategies• Draft non-confidential technical summaries to communicate potential licensing opportunities• Assist in redesigning intern training

Initiated a study to define the role of a Neisseria meningitidis and Neisseria gonorrhoeae genetic element that may be required for invasive gonococcal and meningococcal disease. Principal Investigator: Dr. Anna Karls* Applied genetic and biochemical approaches to characterize and modify the mobility of a pathogenic genetic element in various bacterial backgrounds.* Coordinated with the CDC to characterize meningococcal clinical strains.* Provided leadership as a senior lab member by training multiple graduate and undergraduate rotations on proper laboratory technique and handling of high-consequence biological agents.

Project Scope: Used molecular biology, immunofluorescence microscopy, and biochemical analysis to identify a chaperone protein required for assembly of the Mycoplasma pneumoniae attachment organelle, which has been implicated in cell division, motility, and attachment to epithelial host cells.Principal Investigator: Dr. Duncan C. KrauseDissertation title: Identification and Characterization of a Mycoplasma pneumoniae J-domain Co-Chaperone Required for Terminal Organelle Maturation.* Designed genetic, microscopic, and biochemical approaches to characterize the J-domain chaperone protein of Mycoplasma pneumoniae. * Developed a unique method for identifying real-time protein turnover in mycoplasma to identify a key mechanism of mycoplasma cell development.* Invited to multiple national and international conferences as a speaker or presenter, advised the scientific community on the public health impact of my research.* Elected President of Microbiology Graduate Student Association: collected graduate student concerns and issues and worked with faculty to achieve a solution. Recruited prospective students and coordinated recruiting activities.

Introductory Applied Microbiology MIBO 3000 (1 Semester)Microorganisms, with special emphasis on the structure, function, and diversity of bacteria and their importance to man. Experimental Microbiology Laboratory MIBO 4600L (1 Semester) Molecular analysis of bacteria with emphasis on genetics, metabolism, pathogenesis, and diversity.

Proficient Internet solutions architect that gathered customer requirements, designed IT deployments, negotiated pricing, assembled contracts, and implemented web hosting solutions for over 200 companies with $10,000,000 in annual sales.* Skilled negotiator and collaborator that quickly grasped core objectives, adapted to changing requirements, thendesigned and presented recommendations prioritized by cost / benefit.* Performed Gembas and led Kaizens leading to Standard Work or Organizational Restructuring - Created a uniform pricing strategy for improved business scalability and efficiency; trained team memberswith documented guidelines. - Reorganizing the change management process resulting in increased customer satisfaction andorganizational productivity.

General Biology BIOL 1107: Concepts in Biology Laboratory.An introductory biology lab exploring basic applications of general biology.

Localized the cytadherence protein P30 of Mycoplasma pnuemoniae by phase contrast immunofluorescence microscopy. Primary Investigator: Dr. Duncan C. Krause

Project Scope: Studied the synergistic enzymatic activity of xylanase, XynA, from Orpinomyces sp. Strain PC-2 and ferulic acid esterase, FaeZ, from Clostridium thermocellum on various forms of biomass to maximize ferulic acid and xylose production.Primary Investigator: Dr. Lars J. Ljungdahl